Research aarkstore enterprise diabetes, metabolic syndrome and cardiovascular disease
Upcoming SlideShare
Loading in...5

Research aarkstore enterprise diabetes, metabolic syndrome and cardiovascular disease






Total Views
Views on SlideShare
Embed Views



0 Embeds 0

No embeds



Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
Post Comment
Edit your comment

Research aarkstore enterprise diabetes, metabolic syndrome and cardiovascular disease Research aarkstore enterprise diabetes, metabolic syndrome and cardiovascular disease Document Transcript

  • ResearchAarkstore Enterprise Diabetes, Metabolic Syndrome and Cardiovascular Disease has been a dramatic increase in the incidence of diabetes worldwide, which has beenexacerbated by the growing obesity problem across the globe. Once thought of as primarily achildhood disease--sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes--theobesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diethas resulted in skyrocketing rates of diabetes among adults across the world. To compound theglobal diabetes epidemic, health professionals are witnessing an alarming increase ininflammatory diseases resulting from adult onset (i.e., Type 2) diabetes. This phenomenon isreferred to as "metabolic syndrome" where a confluence of inflammatory conditions occuralong with the diabetes. As a result, growing evidence appears to show that metabolicsyndrome makes the diabetic patient susceptible to degenerative health conditions such ascardiovascular disease, stroke and, now believed, Alzheimers disease. As the diabetes epidemicescalates, a new sense of urgency has taken hold. Proactive strategies for prevention of thedisease are being put in place by international health organizations such as the World HealthOrganization (WHO), as well as by the health departments of industrialized and developingcountries, and even at the local level where food ingredients regulations are being passed. Thisreport charts the changing landscape of the global diabetic population and explores the addedhealth concerns resulting from the metabolic syndrome phenomenon and one of its major riskfactors: cardiovascular disease (CVD). Furthermore, this study evaluates widely-acceptedtherapeutic approaches to diabetes that are currently in use, while providing an in-depthanalysis of emerging technologies that will be used to treat diabetes and other inflammatorydiseases in the future.Table of Contents :1. Overview 81.1 Statement of Report 81.2 About this Report 81.3 Scope of the Report 9
  • 1.4 Methodology 91.5 Executive Summary 112. Introduction 172.1 Demographics of Diabetes 172.1.1 Worldwide Diabetes 172.1.2 U.S. Diabetes 182.2 Economics of Diabetes 223. Understanding the Metabolic Conditions Underlying and Associated with Diabetes 283.1 Pre-Diabetes Syndrome 293.2 Metabolic Syndrome 293.3 Diabetes and Inflammation 323.4 Progression of Diabetes 323.5 Complications and Co-Morbidities in Type 2 Diabetes 333.6 Hypoglycemia and Treatment 383.7 Risk Factors and Diabetes 393.8 Cardiovascular Disease (CVD) Facts 404. Pharmaceutical Industry and the Anti-Diabetes Market 514.1 The Worldwide Pharmaceutical Industry 514.2 Total Diabetes Drug Market Size and Growth 584.2.1 Sales of Anti-Diabetic Drugs Continue to Rise 614.3 Epidemiology/Cost of Treatment 624.4 Diabetic Medications Overview 634.4.1 Recent Trends in Diabetic Drug Usage 634.4.2 Market Influence Factors 67
  • For more information please visit link: EnterprisePhone:08149852585Email:enquiry@aarkstore.comURL:www.aarkstore.com Breast Cancer Therapies Markets HIV-AIDS Testing Markets Over-the-Counter Diagnostic Products World Markets DNA Sequencing and PCR Markets Medical Imaging Markets Clinical Laboratory Testing Volume 2: Key Players for Laboratory Testing, BusinessTrends and Strategies Clinical Laboratory Testing Volume 1: IVD Reagents and Instruments Markets Diabetes, Metabolic Syndrome and Cardiovascular Disease Catheter Markets Blood Glucose Testing and Diabetes Management Global Flow Cytometry Market U.S. Glucose Testing Markets High-Growth Diagnostic Testing Markets European Point of Care Diagnostic Testing Markets Disposable Syringe Markets Point of Care Diagnostic Testing World Markets Disposable Medical Supplies Markets
  • Molecular Diagnostics in Infectious Disease TestingCompanion Diagnostics in Personalized Medicine and Cancer TherapyWorld Glucose Self-Testing MarketsVeterinary Health MarketsPoint of Care Diagnostic Testing Sector TrendsCardiac Marker Diagnostic Testing MarketsMass Spectroscopy for Clinical Laboratory AnalysisCardiac Rhythm Management Devices World MarketsPicture Archiving and Communications Systems (PACS)Biomarker Technology Platforms for Cancer Diagnoses and TherapiesCancer Diagnostic Testing World MarketsPositron Emission Tomography (PET) MarketsMolecular Diagnostics MarketsMolecular Diagnostics in Cancer TestingDrugs of Abuse Testing MarketsUltrasound MarketsNuclear Cardiology MarketsMedical Imaging BundleCancer Vaccines MarketsEuropean Medical Imaging MarketsRespiratory Therapeutics and Devices MarketsDiagnostics BundleMammography World MarketsIndias In Vitro Diagnostic Testing IndustryOrthopedics MarketsCell-Based Assays for Drug DiscoveryCytology and HPV Testing World MarketsClinical Chemistry AnalyzersClinical Immunoanalyzer MarketsMicroscopy MarketsAutomated Microbial Testing MarketsAnti-Infective Drugs MarketsPlastic Surgery Markets